Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors

Thomas Frogne, Anne-Vibeke Laenkholm, Maria B Lyng, Katrine L Henriksen and Anne E Lykkesfeldt*

Breast Cancer Research 2009, 11:R11 doi:10.1186/bcr2230

Accesses  

  • Last 30 days: 57 accesses
  • Last year: 869 accesses
  • All time: 4346 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer

Isabel F Pinhel, Fiona A MacNeill, Margaret J Hills, Janine Salter, Simone Detre, Roger A'Hern, Ashutosh Nerurkar, Peter Osin, Ian E Smith, Mitch Dowsett Breast Cancer Research 2010, 12:R76 (28 September 2010)

Research   Open Access Highly Accessed

Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response

Ramaswamy Bhuvaneswari, Yik Gan, Khee Soo, Malini Olivo Molecular Cancer 2009, 8:94 (2 November 2009)